This controversial rule could change how doctors profit from using the most expensive drugs

The Washington Post
April 11, 2016

A controversial effort by the Obama administration to reform how doctors earn money from administering injection drugs would reduce their earnings on the most expensive drugs while making many older generics more lucrative, according to a new analysis. Read the full article here.